Aortic arch calcification and risk of all-cause mortality and cardiovascular disease : The Guangzhou Biobank Cohort Study
© 2022 The Author(s)..
Background: There were no reports on the associations of aortic arch calcification (AAC) measured by chest X-ray with all-cause mortality and cardiovascular disease (CVD) in older general population. Moreover, previous studies of hemodialysis patients showed that AAC was correlated with left ventricular hypertrophy (LVH) and predicted CVD jointly. Whether the effects remained in the general population is unknown. We examined the associations of AAC with all-cause mortality and CVD in general population and the risk associated with the coexistence of AAC and LVH.
Methods: Presence and severity (grades 0-2) of AAC were measured by chest X-ray, and LVH was identified by 12-lead electrocardiogram in 27,166 Chinese aged 50+ years free of CVD from Guangzhou Biobank Cohort Study. Multivariate Cox regressions were used to examine associations of AAC and LVH with outcomes.
Findings: During an average follow-up of 14·3 years, 5,350 deaths and 4,012 CVD occurred. Compared to those without AAC at baseline, those with AAC had higher risks of all-cause mortality (HR 1·24, 95% CI 1·17-1·31) and CVD (HR 1·22, 95% CI 1·14-1·30), with dose-response relationship (P ≤ 0·001). Furthermore, those with coexistence of AAC and LVH had higher risks of all-cause mortality (HR 1·72, 95% CI 1·37-2·15) and CVD (HR 1·80, 95% CI 1·40-2·32) than those without AAC and LVH.
Interpretation: As chest X-ray has been performed commonly for health screening and in hospital patients when first admitted, AAC measured by chest X-ray can be further applied to assist cardiovascular risk stratification in the community and clinical settings.
Funding: The Natural Science Foundation of China (No. 81941019).
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:23 |
|---|---|
| Enthalten in: |
The Lancet regional health. Western Pacific - 23(2022) vom: 18. Juni, Seite 100460 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Tian, Wen Bo [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Revised 16.07.2022 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1016/j.lanwpc.2022.100460 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM340710969 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM340710969 | ||
| 003 | DE-627 | ||
| 005 | 20231226010057.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.lanwpc.2022.100460 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1135.xml |
| 035 | |a (DE-627)NLM340710969 | ||
| 035 | |a (NLM)35542894 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Tian, Wen Bo |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Aortic arch calcification and risk of all-cause mortality and cardiovascular disease |b The Guangzhou Biobank Cohort Study |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 16.07.2022 | ||
| 500 | |a published: Electronic-eCollection | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a © 2022 The Author(s). | ||
| 520 | |a Background: There were no reports on the associations of aortic arch calcification (AAC) measured by chest X-ray with all-cause mortality and cardiovascular disease (CVD) in older general population. Moreover, previous studies of hemodialysis patients showed that AAC was correlated with left ventricular hypertrophy (LVH) and predicted CVD jointly. Whether the effects remained in the general population is unknown. We examined the associations of AAC with all-cause mortality and CVD in general population and the risk associated with the coexistence of AAC and LVH | ||
| 520 | |a Methods: Presence and severity (grades 0-2) of AAC were measured by chest X-ray, and LVH was identified by 12-lead electrocardiogram in 27,166 Chinese aged 50+ years free of CVD from Guangzhou Biobank Cohort Study. Multivariate Cox regressions were used to examine associations of AAC and LVH with outcomes | ||
| 520 | |a Findings: During an average follow-up of 14·3 years, 5,350 deaths and 4,012 CVD occurred. Compared to those without AAC at baseline, those with AAC had higher risks of all-cause mortality (HR 1·24, 95% CI 1·17-1·31) and CVD (HR 1·22, 95% CI 1·14-1·30), with dose-response relationship (P ≤ 0·001). Furthermore, those with coexistence of AAC and LVH had higher risks of all-cause mortality (HR 1·72, 95% CI 1·37-2·15) and CVD (HR 1·80, 95% CI 1·40-2·32) than those without AAC and LVH | ||
| 520 | |a Interpretation: As chest X-ray has been performed commonly for health screening and in hospital patients when first admitted, AAC measured by chest X-ray can be further applied to assist cardiovascular risk stratification in the community and clinical settings | ||
| 520 | |a Funding: The Natural Science Foundation of China (No. 81941019) | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a AAC, aortic arch calcification | |
| 650 | 4 | |a Aortic arch | |
| 650 | 4 | |a CT, computed tomography | |
| 650 | 4 | |a CVD, cardiovascular disease | |
| 650 | 4 | |a Cardiovascular disease | |
| 650 | 4 | |a GBCS, Guangzhou Biobank Cohort Study | |
| 650 | 4 | |a IHD, ischemic heart disease | |
| 650 | 4 | |a LVH, left ventricular hypertrophy | |
| 650 | 4 | |a MI, myocardial infarction | |
| 650 | 4 | |a Mortality | |
| 650 | 4 | |a Risk factor | |
| 650 | 4 | |a Vascular calcification | |
| 700 | 1 | |a Zhang, Wei Sen |e verfasserin |4 aut | |
| 700 | 1 | |a Jiang, Chao Qiang |e verfasserin |4 aut | |
| 700 | 1 | |a Liu, Xiang Yi |e verfasserin |4 aut | |
| 700 | 1 | |a Jin, Ya Li |e verfasserin |4 aut | |
| 700 | 1 | |a Lam, Tai Hing |e verfasserin |4 aut | |
| 700 | 1 | |a Cheng, Kar Keung |e verfasserin |4 aut | |
| 700 | 1 | |a Xu, Lin |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The Lancet regional health. Western Pacific |d 2020 |g 23(2022) vom: 18. Juni, Seite 100460 |w (DE-627)NLM320728897 |x 2666-6065 |7 nnns |
| 773 | 1 | 8 | |g volume:23 |g year:2022 |g day:18 |g month:06 |g pages:100460 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.lanwpc.2022.100460 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 23 |j 2022 |b 18 |c 06 |h 100460 | ||